Evidence map›Paper›PMID 28925954›Full record

ArticleMolecules (Basel, Switzerland)2017

Quantitative Structure-Activity Relationship Modeling of Kinase Selectivity Profiles.

Sandeepkumar Kothiwale, Corina Borza, Ambra Pozzi, Jens Meiler

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sandeepkumar KothiwaleDepartment of Chemistry, Center for Structural Biology, Institute of Chemical Biology Vanderbilt University, Nashville, TN 37232, USA. kothiwale.sandeep@gmail.com.
Corina BorzaDepartment of Medicine, Division of Nephrology, Vanderbilt University, Nashville, TN 37232, USA. corina.borza@vanderbilt.edu.
Ambra PozziDepartment of Medicine, Division of Nephrology, Vanderbilt University, Nashville, TN 37232, USA. ambra.pozzi@vanderbilt.edu.
Jens MeilerDepartment of Chemistry, Center for Structural Biology, Institute of Chemical Biology Vanderbilt University, Nashville, TN 37232, USA. jens@meilerlab.org.
Vanderbilt University · US

Funding

Vanderbilt O'Brien Kidney Center - Core D - Clinical and Translational CoreP30DK114809 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, RAYMOND C. · 2017 to 2021
$5.9M
Integrin/TGF-beta Axis in Tubulointerstitial FibrosisR01DK095761 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI POZZI, AMBRA · 2013 to 2016
$1.4M
Computational Design of Protein-Ligand Interfaces - a Therapeutic StrategyR01GM099842 · NIGMS · VANDERBILT UNIVERSITY · PI MEILER, JENS · 2012 to 2015
$1.3M
Small Molecule Probes to Investigate Structure and Function of Y ReceptorsR01DK097376 · NIDDK · VANDERBILT UNIVERSITY · PI MEILER, JENS, WEAVER, C DAVID · 2013 to 2015
$1.0M
GPU-Accelerated Parallel Computer for Drug Discovery ApplicationsS10OD020154 · OD · VANDERBILT UNIVERSITY · PI SMITH, JARROD ANSON · 2015 to 2015
$225k
Role of Collagen Binding Receptors in GlomerulosclerosisI01BX002025 · VA · VETERANS HEALTH ADMINISTRATION · PI AMBRA POZZI · 2013 to 2026
–
BLRD VA I01 BX002025NIDDK NIH HHS P30 DK114809NIDDK NIH HHS R01 DK095761NIDDK NIH HHS R01 DK097376NIGMS NIH HHS R01 GM099842
6 · The paper itself

Abstract

The discovery of selective inhibitors of biological target proteins is the primary goal of many drug discovery campaigns. However, this goal has proven elusive, especially for inhibitors targeting the well-conserved orthosteric adenosine triphosphate (ATP) binding pocket of kinase enzymes. The human kinome is large and it is rather difficult to profile early lead compounds against around 500 targets to gain an upfront knowledge on selectivity. Further, selectivity can change drastically during derivatization of an initial lead compound. Here, we have introduced a computational model to support the profiling of compounds early in the drug discovery pipeline. On the basis of the extensive profiled activity of 70 kinase inhibitors against 379 kinases, including 81 tyrosine kinases, we developed a quantitative structure-activity relation (QSAR) model using artificial neural networks, to predict the activity of these kinase inhibitors against the panel of 379 kinases. The model's performance in predicting activity ranges from 0.6 to 0.8 depending on the kinase, from the area under the curve (AUC) of the receiver operating characteristics (ROC). The profiler is available online at http://www.meilerlab.org/index.php/servers/show?s_id=23.

Indexed as

Models, MolecularAdenosine TriphosphateArea Under CurveBinding SitesDatabases, PharmaceuticalDrug DiscoveryNeural Networks, ComputerProtein BindingProtein ConformationProtein Kinase InhibitorsProtein-Tyrosine KinasesQuantitative Structure-Activity RelationshipROC CurveSoftwareAdenosine TriphosphateProtein Kinase InhibitorsProtein-Tyrosine Kinasesartificial neural networksBCL::C">heminfokinase selectivity profilequantitative structure–activity relation

Identifiers

PMID28925954
PMCPMC6151389
OpenAlexW2755050806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.